Teva Gets FTC Okay For Cephalon Deal After Reducing Its Generic Provigil Exclusivity
This article was originally published in The Pink Sheet Daily
Executive Summary
Federal Trade Commission amends final order settling charges Teva’s acquisition of Cephalon would have been anticompetitive; agency cites Teva’s deal allowing Mylan to launch its generic Provigil 45 days early.